We are live on ! Find out more
SAGE

Sage Therapeutics
SAGE

Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

200 hedge funds and large institutions have $2.04B invested in Sage Therapeutics in 2022 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 68 increasing their positions, 60 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

259% more call options, than puts

Call options by funds: $23.4M | Put options by funds: $6.52M

24% more capital invested

Capital invested by funds: $1.65B → $2.04B (+$396M)

13% more repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 60

1.55% more ownership

Funds ownership: 86.31% → 87.86% (+1.5%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

4% less funds holding

Funds holding: 209 → 200 (-9)

23% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 30

Holders
200
Holders Change
-9
Holders Change %
-4.31%
% of All Funds
3.45%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
23
Increased
68
Reduced
60
Closed
30
Calls
$23.4M
Puts
$6.52M
Net Calls
+$16.9M
Net Calls Change
+$10.2M

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$26.9M
2
BlackRock
BlackRock
New York
+$22.4M
3
Fisher Asset Management
Fisher Asset Management
Washington
+$17.2M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$16.3M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$13.2M

Top Sellers

Rank Fund Capital Flow
1
Marshall Wace
Marshall Wace
United Kingdom
-$23.7M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$17.7M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$11.7M
4
Morgan Stanley
Morgan Stanley
New York
-$8.99M
5
DTC
Deep Track Capital
Connecticut
-$5.55M
Name Holding Trade Value Shares
Change 		Change in
Stake
CA
176
Crewe Advisors
Utah
$2K – – –
LWCFA
177
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$2K – – –
SPIA
178
Steward Partners Investment Advisory
New York
$2K – – –
TC
179
Truvestments Capital
Florida
$2K – – –
BTI
180
Blue Trust Inc
Georgia
$2K +$928 +24 +49%
SC
181
Schubert & Co
Texas
$2K +$1.04K +27 +193%
AF
182
Allworth Financial
California
$2K +$1.47K +38 +345%
BHWM
183
Beaird Harris Wealth Management
Texas
$1K – – –
BIA
184
Bell Investment Advisors
California
$1K – – –
Carson Wealth (CWM LLC)
185
Carson Wealth (CWM LLC)
Nebraska
$1K – – –
EARNEST Partners
186
EARNEST Partners
Georgia
$1K – – –
MAM
187
Meeder Asset Management
Ohio
$1K – – –
NFSG
188
Newbridge Financial Services Group
Florida
$1K – – –
NSIM
189
North Star Investment Management
Illinois
$1K – – –
QC
190
Quent Capital
New York
$1K – – –
JWA
191
JFS Wealth Advisors
Pennsylvania
$1K +$116 +3 +30%
DFCM
192
Dark Forest Capital Management
Puerto Rico
$1K +$696 +18 +600%
WIM
193
Westside Investment Management
California
$27 – – –
DTC
194
Deep Track Capital
Connecticut
– -$5.55M -171,800 Closed
Voloridge Investment Management
195
Voloridge Investment Management
Florida
– -$4.27M -132,101 Closed
Bank of Nova Scotia
196
Bank of Nova Scotia
Ontario, Canada
– -$2.81M -87,000 Closed
BC
197
Brookfield Corp
Ontario, Canada
– -$2.25M -69,549 Closed
Jane Street
198
Jane Street
New York
– -$2.27M -58,625 Closed
EGM
199
Engineers Gate Manager
New York
– -$1.35M -41,684 Closed
Bank of Montreal
200
Bank of Montreal
Ontario, Canada
– -$1.49K -41,421 Closed
5 6 7
8
9

SAGE Hedge Fund Activity: Q3 2022 in Review

200 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Sage Therapeutics (SAGE) for Q3 2022, worth a combined $2.04B — up 24% from $1.65B a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of SAGE and 23 opened new positions — a net loss of 7 holders — while 60 trimmed existing stakes and 68 added.

The largest buyer was Janus Henderson Group, adding an estimated $26.9M. The largest seller was Marshall Wace, cutting an estimated $23.7M.

  • 200 institutional investors held Sage Therapeutics (SAGE) as of Q3 2022, down from 209 in Q2 2022.
  • Funds reported $2.04B of Sage Therapeutics stock for Q3 2022, up 24% quarter-over-quarter.
  • 23 funds opened new Sage Therapeutics positions in Q3 2022 and 30 closed out, a net change of -7 holders.
  • The largest Sage Therapeutics buyer in Q3 2022 was Janus Henderson Group, an estimated $26.9M added.
  • The largest Sage Therapeutics seller in Q3 2022 was Marshall Wace, an estimated $23.7M sold.

Based on aggregated 13F filings for Q3 2022.